Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-C )

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1622 participants.

Also called NCT06522269

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,622 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06522269
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06522269. Randomized; single masking; primary purpose treatment. Start 2024-08-08 (actual); primary completion 2025-08-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-C )
Condition
Ischemic Stroke, Acute
Intervention (Combination product)
Emergency Stroke Unit based on 0.23-T MRI
Intervention (Combination product)
Standard stroke unit adherent to guidelines
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct06522269
Content hash
e73bf5d116ccd9210d7b7f05656723443c18ed607d346bd5332bccfc29ddeeda